Walgreens Boots Alliance
Related Competitor Intelligence
Compare market positioning with top industry peers
Explore Walgreens Boots Alliance
Core profile pages, annual revenue records, and related research hubs for this company.
Walgreens Boots Alliance
Compare market positioning with top industry peers
Explore Walgreens Boots Alliance
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$147.7B
Market Cap
$9.6B
Employees
212,000
Walgreens Boots Alliance is executing a painful, critical survival restructuring after suffering one of the most catastrophic pharmacy retail collapses of any major US chain in recent decades. Under CEO Tim Wentworth, the pharmacy giant generated exactly $148.0 billion in revenue and maintains a severely distressed $9.6 billion market cap with exactly 212000 employees. The financial narrative in 2026 is entirely defined by store closure program and urgent debt reduction; reversing decades of unprofitable clinic-in-pharmacy overexpansion, Walgreens extracts remaining profitability by furiously closing 1,200+ underperforming stores, exiting its catastrophically failed VillageMD primary care investment, and desperately rebuilding pharmacy margins through aggressive specialty pharmacy and mail-order growth.
Revenue Trend Analysis
YoY Change
+6.2%
3-Year CAGR
+3.7%
Peak Year
2024
Trend
Consistent Growth
Walgreens Boots Alliance has reported revenue across 3 fiscal years, compounding at +3.7% annually over 3 years. The most recent year saw a 6.2% increase versus the prior year. Revenue peaked in 2024 at $147.7B. Out of 2 reported periods, 2 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $147.7B | N/A | +6.2% |
| FY2023 | $139.1B | — | +5.0% |
| FY2021 | $132.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Walgreens Boots Alliance reported approximately $148.0B in fiscal year 2024 with a team of 212,000 employees worldwide.
Walgreens Boots Alliance strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.
Financial performance in Retail Pharmacy and Healthcare is driven by steady cash generation and pricing power, enabling Walgreens Boots Alliance to reinvest in high-return strategic initiatives.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Walgreens Boots Alliance Revenue & Financials." CorpDigest, https://corpdigest.com/company/walgreens-boots-alliance/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Walgreens Boots Alliance reported $148B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/walgreens-boots-alliance/financials" target="_blank" rel="noopener">CorpDigest — Walgreens Boots Alliance financials</a></div>